United States· US:70370-1060_bbfcd3d3-5b8b-411d-9cb6-3521a4e36e6b
INGREZZA
A valbenazine product containing valbenazine tosylate, registered in United States by Neurocrine Biosciences, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VALBENAZINE TOSYLATE
- Manufacturer
- Neurocrine Biosciences, Inc.
- Country
- United States (US)
- ATC code
- N07XX13
- ATC class
- Valbenazine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11703701060130 CAPSULE in 1 BOTTLE (70370-1060-1)
- ndc1170370-1060-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
244 interactions on record for valbenazine.
Graded by severity as the source publishes them — 60 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valbenazine · interactions on record
244 records
- 60 severe
- 180 moderate
- 4 minor
Most severe, free to view
- ClotrimazoleA01AB18severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N07XX13
Valbenazine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/817c5521-0943-4a13-aa35-34ea8fe95606 GET /v1/drugs/817c5521-0943-4a13-aa35-34ea8fe95606?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "60",
"substance": "VALBENAZINE TOSYLATE",
"productndc": "70370-1060",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA209241",
"marketing_category": "NDA"
}See everything about valbenazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.